Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
James E. Flynn | Director | 2025-02-27 | 353,249 | $0.93 | $328.87kBuy |
James E. Flynn | Director | 2025-02-27 | 353,249 | $0.93 | $328.87kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Orbimed Israel Biofund GP Limited Partnership | 52.62% | 13,773,653 | $5.63M | Insider |
Erez Chimovits | 17.68% | 4,626,978 | $1.89M | Insider |
Chidozie Ugwumba | 11.45% | 2,997,025 | $1.23M | Insider |
James E. Flynn | 9.53% | 2,494,108 | $1.02M | Insider |
Deerfield Management Company LP Series C | 9.53% | 2,494,108 | $1.02M | Institution |
Nantahala Capital Management LLC | 9.53% | 2,493,309 | $1.02M | Institution |
Takeda Pharmaceutical Co Ltd | 9.44% | 2,470,935 | $1.01M | Insider |
Jonas Grossman | 7.95% | 2,080,217 | $850.81k | Insider |
Orbimed Advisors LLC | 6.83% | 1,787,767 | $731.20k | Institution |
Fibrosis Foundation Cystic | 6.83% | 1,787,758 | $731.19k | Insider |